Scholay

学术搜索 · AI 审稿 · LaTeX 协作

MA02.02 Updated Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non-Small Cell Lung Cancer: The Global TRUST-II Study

作者:Geoffrey Liu, C.-M. Choi, Shunichi Sugawara, Noriko Yanagitani, Filippo de Braud, J. Nieva, Misako Nagasaka, C. Zhou, E. Felip, X. Zhang, Weiqing Wang, Nathan A. Pennell, M. Pérol, Lyudmila Bazhenova · 发表于:Journal of Thoracic Oncology · 年份:2025 · DOI:10.1016/j.jtho.2025.09.105 · 被引用次数:3 · 研究领域:Lung Cancer Treatments and Mutations、Synthesis and biological activity、Cytokine Signaling Pathways and Interactions